The estimated Net Worth of Michael Zercher is at least $1.57 Million dollars as of 31 August 2022. Mr Zercher owns over 370,789 units of 22nd Century Inc stock worth over $257,002 and over the last 5 years he sold XXII stock worth over $550,563. In addition, he makes $764,501 as Pres & COO at 22nd Century Inc.
Mr has made over 2 trades of the 22nd Century Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 370,789 units of XXII stock worth $500,565 on 31 August 2022.
The largest trade he's ever made was selling 370,789 units of 22nd Century Inc stock on 31 August 2022 worth over $500,565. On average, Mr trades about 56,277 units every 37 days since 2019. As of 31 August 2022 he still owns at least 904,938 units of 22nd Century Inc stock.
You can see the complete history of Mr Zercher stock trades at the bottom of the page.
Michael J. Zercher is the Pres & COO at 22nd Century Inc.
As the Pres & COO of 22nd Century Inc, the total compensation of Mr Zercher at 22nd Century Inc is $764,501. There are 1 executives at 22nd Century Inc getting paid more, with James A. Mish having the highest compensation of $1,140,872.
Mr Zercher is 50, he's been the Pres & COO of 22nd Century Inc since . There are 11 older and 1 younger executives at 22nd Century Inc. The oldest executive at 22nd Century Group Inc is Roger O'Brien, 71, who is the Independent Director.
Michael's mailing address filed with the SEC is 500 SENECA STREET, SUITE 507, , BUFFALO, NY, 14204.
Over the last 11 years, insiders at 22nd Century Inc have traded over $3,035,006 worth of 22nd Century Inc stock and bought 652,225 units worth $737,196 . The most active insiders traders include Andrew Arno, Joseph Pandolfino und Michael Zercher. On average, 22nd Century Inc executives and independent directors trade stock every 80 days with the average trade being worth of $16,372. The most recent stock trade was executed by Lawrence Firestone on 30 May 2024, trading 9,000 units of XXII stock currently worth $9,810.
with the mission of reducing the harm caused by smoking, 22nd century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. goodrich tobacco company and hercules pharmaceuticals are wholly-owned subsidiaries focusing on (i) premium cigarettes and potentially reduced risk tobacco products (with up to 97% less nicotine than conventional cigarettes), and (ii) the x-22 prescription smoking cessation aid in development. 22nd century's technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.
22nd Century Inc executives and other stock owners filed with the SEC include: